BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32274125)

  • 1. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
    Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
    J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study.
    Wang S; Zhang Z; Gu Y; Lv X; Shi X; Liu M
    Front Oncol; 2021; 11():726811. PubMed ID: 34956862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer.
    Wo Y; Zhao Y; Qiu T; Li S; Wang Y; Lu T; Qin Y; Song G; Miao S; Sun X; Liu A; Kong D; Dong Y; Leng X; Du W; Jiao W
    Cancer Med; 2019 Feb; 8(2):669-678. PubMed ID: 30706688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study.
    Ling L; Zheng H; Lin H; Ge C; Li D; Wu L; Lou Y; Jiang T; Fu J
    Clin Lung Cancer; 2023 May; 24(3):e141-e151. PubMed ID: 36639280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size.
    Huang W; Deng HY; Lin MY; Xu K; Zhang YX; Yuan C; Zhou Q
    Front Oncol; 2022; 12():830470. PubMed ID: 35280762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying optimal surgical approach among T1N2-3M0 non-small cell lung cancer patients: a population-based analysis.
    Ge T; Hu SQ; Ning J; Zhou YF; Bian DL; Teng MX; Chen LS; Yang J
    Transl Lung Cancer Res; 2024 Apr; 13(4):901-929. PubMed ID: 38736488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-lung cancer specific mortality after lobectomy or sublobectomy in patients with stage IA non-small cell lung cancer ≤2 cm: A propensity score analysis.
    Yin J; Zhao M; Lu T; Huang Y; Sui Q; Xi J; Lin Z; Xu S; Wang Q; Zhan C
    J Surg Oncol; 2019 Dec; 120(8):1486-1496. PubMed ID: 31602661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of visceral pleural invasion in the stage pT
    Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
    Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral pleural invasion in T1 tumors (≤3 cm), particularly T1a, in the eighth tumor-node-metastasis classification system for non-small cell lung cancer: a population-based study.
    Zhang T; Zhang JT; Li WF; Lin JT; Liu SY; Yan HH; Yang JJ; Yang XN; Wu YL; Nie Q; Zhong WZ
    J Thorac Dis; 2019 Jul; 11(7):2754-2762. PubMed ID: 31463103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis.
    Ma H; Cheng J; Yu Y; Liu B; Qin J; Xing W; Luo S
    J Thorac Dis; 2021 Jan; 13(1):312-321. PubMed ID: 33569211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of the surgical approach for patients with stage I lung squamous cell carcinoma ≤3 cm.
    Chen C; Wang Y; Pan X; Fu S; Shi Y; Yang J; Wang R
    J Thorac Dis; 2018 Dec; 10(12):6771-6782. PubMed ID: 30746222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry.
    Yang X; Sun F; Chen L; Shi M; Shi Y; Lin Z; Feng M; Zhan C; Jiang W; Wang Q
    J Surg Oncol; 2017 Sep; 116(3):398-406. PubMed ID: 28543219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies.
    Fan J; Wang L; Jiang GN; Gao W
    Ann Surg Oncol; 2012 Feb; 19(2):661-8. PubMed ID: 21769464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study.
    Wang L; Ge L; You S; Liu Y; Ren Y
    J Cardiothorac Surg; 2022 May; 17(1):110. PubMed ID: 35545793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer.
    Mu JW; Gao SG; Xue Q; Zhao J; Li N; Yang K; Su K; Yuan ZY; He J
    Chin Med J (Engl); 2015 Oct; 128(20):2731-5. PubMed ID: 26481738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of visceral pleural involvement in early-stage lung cancer.
    Lakha S; Gomez JE; Flores RM; Wisnivesky JP
    Chest; 2014 Dec; 146(6):1619-1626. PubMed ID: 25032521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study.
    Liu Y; Huang C; Liu H; Chen Y; Li S
    World J Surg Oncol; 2014 May; 12():138. PubMed ID: 24886396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical outcomes after thoracoscopic sublobectomy versus lobectomy for Stage I nonsmall cell lung cancer: A meta-analysis.
    Liu Q; Wang H; Zhou D; Deng X; Min J; Dai J
    J Cancer Res Ther; 2016; 12(2):926-31. PubMed ID: 27461676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
    Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
    Front Oncol; 2021; 11():784289. PubMed ID: 35155190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The modification of T description according to visceral pleural invasion and tumor size from 3.1 cm to 4.0 cm in non-small cell lung cancer: A retrospective analysis based on the SEER database.
    Qi M; Bian D; Zhang J; Zhu X; Zhou C; Zhang L
    Lung Cancer; 2021 Aug; 158():47-54. PubMed ID: 34119932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.